ID: ALA5205108

Max Phase: Preclinical

Molecular Formula: C18H27NOS

Molecular Weight: 305.49

Associated Items:

Representations

Canonical SMILES:  CSC1(C)CCC2C(C)CCC(c3ccccc3)N2C1O

Standard InChI:  InChI=1S/C18H27NOS/c1-13-9-10-16(14-7-5-4-6-8-14)19-15(13)11-12-18(2,21-3)17(19)20/h4-8,13,15-17,20H,9-12H2,1-3H3

Standard InChI Key:  AYWYBFVFYLDQNT-UHFFFAOYSA-N

Associated Targets(Human)

U-937 7138 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.49Molecular Weight (Monoisotopic): 305.1813AlogP: 4.06#Rotatable Bonds: 2
Polar Surface Area: 23.47Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.84CX Basic pKa: 8.95CX LogP: 4.37CX LogD: 2.81
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.89Np Likeness Score: 1.20

References

1. Rodrigues L, Tilve SG, Majik MS..  (2021)  Synthetic access to thiolane-based therapeutics and biological activity studies.,  224  [PMID:34237621] [10.1016/j.ejmech.2021.113659]

Source